Day: January 24, 2022
CHARLOTTE, N.C., Jan. 24, 2022 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that financial advisors Andy Walker and Christian Covey have launched a new practice, Walker Covey Wealth Advisors, through affiliation with LPL Strategic Wealth Services model. Previously, the advisors were part of a firm working with approximately $350 million in advisory, brokerage and retirement plan assets.* They join LPL from Commonwealth.
Based in Utah County, Walker and Covey are Brigham Young University graduates who teamed up to combine their strengths in order to help clients better understand their finances and investments. “Working together, we’ve built a strong trust in each other. We’re both grounded in our philosophy and systematic processes focused on principle-based investing,” said Walker, managing partner and chief...
Cemtrex Reports Fourth Quarter and Full Year 2021 Financial Results
Written by Customer Service on . Posted in Public Companies.
Fourth Quarter Revenues Increase 37% to $14.7 Million
Brooklyn, NY, Jan. 24, 2022 (GLOBE NEWSWIRE) — – Cemtrex Inc. (NASDAQ: CETX, CETXP, CETXW), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, has reported its financial and operational results for the fourth quarter and year ended September 30, 2021.
Key Fourth Quarter 2021 HighlightsLaunched the SmartDesk Connect D, a new version that extends compatibility to more devices including most mid- to high-end laptops, Apple® M1 products and select Microsoft Surface® devices.
Bravo Strong has continued with the development of first VR game and expects a beta release of StarForceVR in Oculus Quest App Lab in CY22 Q1.
Appointed independent directors Chris Wagner,...
Motorsport Games’ Le Mans Virtual Series followed by more than 81 million fans on live TV, digital streaming and social media throughout the 2021-2022 season
Written by Customer Service on . Posted in Public Companies.
The series concludes its 5-month season with racing legends, millions of fans and hundreds of lapsLMVSSeason FinaleMIAMI, Jan. 24, 2022 (GLOBE NEWSWIRE) — The five-round 2021-22 Le Mans Virtual Series, which was brought to a glittering conclusion last weekend with the star-studded 24 Hours of Le Mans Virtual, registered impressive, cumulated TV and digital audience figures of more than 81 million throughout its 5-month season.
The grand finale to the Le Mans Virtual Series held on January 15 and 16, 2022 brought together 50 cars with 200 drivers hailing from 39 different countries. Racers competed on 116 simulators worldwide located in 28 countries on an extremely accurate virtual rendition of the iconic Circuit des 24 Heures in Le Mans, France. Heading a grid of famous racing names and leading the charge in...
CareTrust REIT, Inc. Announces Tax Treatment of 2021 Dividends
Written by Customer Service on . Posted in Public Companies.
SAN CLEMENTE, Calif., Jan. 24, 2022 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) reported today the tax status of its 2021 dividends paid to shareholders. Details on the classifications of the dividends are included in the table below:DISTRIBUTIONS ON CARETRUST COMMON STOCK
Box 1a
Box 1b
Box 2a
Box 2b
Box 3
Box 5
Unrecap.
Qualified
Section
Taxable
Dividend
1250 Gain
SectionRecord
Payment
Distribution
Distribution
Ordinary
(Included in
Capital
(Included in
Non-Dividend
199ADate
Date
Per Share
Per Share
Dividend
Box 1a)
Gain Distr.
Box 2a)
Distributions
Dividend12/31/20
01/15/21
$
0.2500
$
0.2500
90.0562
%
0.0000
%
0.0000
%
0.0000
%
9.9438
%
90.0562
%03/31/21
04/15/21
$
0.2650
$
0.2650
90.0562
%
0.0000
%
0.0000
%
0.0000
%
9.9438
%
90.0562
%06/30/21
07/15/21
$
0.2650
$
0.2650
90.0562
%
0.0000
%
0.0000
%
0.0000
%
9.9438
%
90.0562
%09/30/21
10/15/21
$
0.2650
$
0.2650
90.0562
%
0.0000
%
0.0000
%
0.0000
%
9.9438
%
90.0562
%12/31/21
01/15/22
$
0.2650
$
–
(1
)
0.0000
%
0.0000
%
0.0000
%
0.0000
%
0.0000
%
0.0000
%Total
$
1.3100
$
1.0450
90.0562
%
0.0000
%
0.0000
%
0.0000
%
9.9438
%
90.0562
%(1)...
Udemy to Report Fourth Quarter Fiscal Year 2021 Results on February 9, 2022
Written by Customer Service on . Posted in Public Companies.
SAN FRANCISCO, Jan. 24, 2022 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today announced it will release its financial results for its fourth quarter ended December 31, 2021, after market close on February 9, 2022.
Udemy will host a conference call and earnings webcast beginning at 5:00 p.m. EST / 2:00 p.m. PST on the same day to discuss the company’s financial results. Interested parties may access the conference call by registering here. The conference call will also be webcast live on the Udemy Investor Relations website at https://investors.udemy.com/.
Shortly after the conclusion of the live earnings call, an archived replay of the webcast will be available on the Udemy Investor Relations website at https://investors.udemy.com/.
About UdemyUdemy’s (Nasdaq: UDMY) mission...
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting
Written by Customer Service on . Posted in Public Companies.
Interim data presented in poster reflects median overall survival of 12.0 months, not yet final, and an objective response rate of 48%, both greater than historical rates reported for standard of careMINNEAPOLIS, Jan. 24, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced the presentation of interim clinical data from its Phase 1b combination therapy study of SBP-101, a proprietary polyamine analogue, with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma (PDA), at the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Meeting that took place January 20-22, 2022.
Jennifer K. Simpson, PhD, MSN, CRNP President & Chief...
RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor
Written by Customer Service on . Posted in Public Companies.
Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) — RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because of the overwhelming response from the public and medical field from our pending DeltaWave 510k approval and market release.
“We feel we owe it to our current and future investors to have partnered with a gold star firm to assist us with our investor relations moving forward. Maintaining an open line of communication with our shareholders and providing...
Lithium Market to Worth USD 8.24 Billion by 2027 | Global Lithium Industry Growth, Demand, Outlook and Forecast Report by Fortune Business Insights™
Written by Customer Service on . Posted in Mergers And Acquisitions.
companies covered in the lithium market are Tianqi Lithium (Australia), International Lithium Corp. (China), FMC Corporation (India), Albemarle Corporation (U.S.), SQM S.A. (Chile), LSC Lithium Corporation (Canada), American Lithium Corp. (Canada), Livent (U.S.), Avalon Advanced Materials (Canada), Sayona Mining Limited (Australia), and more players profiled
Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights™, the global lithium market size is projected to reach USD 8.24 billion by the end of 2027. The presence of several large scale companies in several countries across the world will emerge in favor of the growth of the global lithium market. Lithium is a chemical element that is present in natural substances such as rocks. The material is approved for use in several industry verticals, including...
North America Sugar-Free Chocolate Market to Reach USD 391.8 Million by 2028 | North America Sugar-Free Chocolate Industry Trends, Growth, and Forecast Report by Fortune Business Insights™
Written by Customer Service on . Posted in Mergers And Acquisitions.
Companies covered in North America sugar-free chocolate market report are The Hershey Company (Pennsylvania, U.S.), Ferrero SpA (Alba, Italy), Chocoladefabriken Lindt & Sprüngli AG (Kilchberg, Switzerland), Godiva Chocolatier (Midtown Manhattan, U.S.), KOHLER Co. (Wisconsin, U.S.), Jackie’s Chocolate (Wisconsin, U.S.), Pascha Chocolate (Toronto, Canada), Pobeda Confectionery Ltd. (Moscow, Russia), Asher’s Chocolate Company (Pennsylvania, U.S.), Barry Callebaut AG (Zürich, Switzerland), and other players profiled
Pune, India, Jan. 24, 2022 (GLOBE NEWSWIRE) — The global North America sugar-free chocolate market size is expected to touch USD 391.8 million by 2028, exhibiting a CAGR of 5.42% during the forecast period. The market value stood at USD 242.0 million in 2020 and reached USD 270.7 million in 2021. Increasing health...
Todos Medical Announces Data Lock in Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
Written by Customer Service on . Posted in Public Companies.
New York, NY, and Tel Aviv, ISRAEL, Jan. 24, 2022 (GLOBE NEWSWIRE) — § Clinical Data Will be Released Thursday, January 27th, 2022
via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease theragnostic joint venture partner NLC Pharma Ltd., today announced a data lock for the interim data analysis for the Company’s Tollovir™ Phase 2 Clinical Trial for the treatment of hospitalized (severe/critical) COVID-19 patients. The Company will release the results on Thursday, January 27th, 2022.
“We are very excited to see the first controlled clinical trial data for Tollovir,” said Dr. Dorit Arad, Founder & Chief Scientific Officer of NLC Pharma, Todos Medical’s 3CL protease biology theragnostics joint venture partner. “We are also...